Skip to main content
Jinhe Biotechnology CO.,LTD. logo

Jinhe Biotechnology CO.,LTD. — Investor Relations & Filings

Ticker · 002688 ISIN · CNE100001HK7 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,830 across all filing types
Latest filing 2026-05-22 Notice of Dividend Amou…
Country CN China
Listing Shenzhen Stock Exchange 002688

About Jinhe Biotechnology CO.,LTD.

https://www.jinhe.com.cn

Jinhe Biotechnology CO.,LTD. specializes in the research, development, and manufacturing of animal health products and feed additives. The company is a prominent global producer of chlortetracycline (CTC), maintaining extensive production capacity for feed-grade antibiotics. Its diverse product portfolio includes veterinary pharmaceuticals such as salinomycin and monensin, alongside a range of biological products and animal vaccines. Jinhe Biotechnology leverages advanced fermentation technology and integrated research capabilities to provide solutions for the livestock and poultry sectors. The company focuses on improving animal growth performance and disease prevention through standardized production processes and a global distribution network. Its operations span the development of specialized additives and the provision of comprehensive veterinary medical products designed to support large-scale animal husbandry.

Recent filings

Filing Released Lang Actions
2025年年度权益分派实施公告
Notice of Dividend Amount Classification · 95% confidence The document is a formal announcement by 金河生物科技股份有限公司 detailing the implementation of the 2025 equity distribution (cash dividend) plan, including dividend per share, record date, ex-dividend date, total distribution amount, tax treatment, and payout logistics. It is clearly a Notice of Dividend Amount intended to inform shareholders about dividend details and payment arrangements rather than an annual report or financial statements. Therefore, it should be classified as DIV.
2026-05-22 Chinese
关于参加内蒙古辖区上市公司2026年投资者网上集体接待日活动的公告
Regulatory Filings Classification · 65% confidence The document is a brief announcement by Jinhe Biology about its participation in a virtual investor reception day event organized by the Inner Mongolia regulatory bureau. It does not contain financial statements, voting details, management changes, or dividend information. It merely informs investors of an upcoming interactive session and how to participate. It is a general regulatory announcement that doesn’t fit any more specific category, thus it should be classified as Regulatory Filings (RNS).
2026-05-21 Chinese
第七届董事会第一次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of resolutions from the company’s Board of Directors meeting, detailing the election of board leadership, committee appointments, and the hiring of senior management (general manager, CFO, board secretary, etc.). It does not contain financial statements, regulatory filings by reference only, or investor presentation materials. This fits the definition of a Board/Management Information announcement (code MANG).
2026-05-21 Chinese
关于职工代表董事换届选举的公告
Board/Management Information Classification · 88% confidence The document is an announcement by Jinh e Biotech regarding the election of a new employee‐representative director to the company’s Board of Directors. It details the board change, the election process, qualifications of the newly elected director, and confirms compliance with relevant laws and corporate bylaws. This fits the Board/Management Information category (announcement of changes in the company's board of directors).
2026-05-21 Chinese
关于子公司获得兽药产品批准文号批件的公告
Regulatory Filings
2026-05-08 Chinese
关于注销部分募集资金专户的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the cancellation of a portion of a special fundraising account related to a non-public stock issuance. It details the background of the fundraising, the management and use of the funds, and the specific cancellation of the fundraising account. The document is short (1355 characters) and does not contain financial statements or detailed financial data. It is an announcement about a capital/fundraising activity, specifically the cancellation of a fundraising account, which fits best under Capital/Financing Update (CAP).
2026-01-21 Chinese

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.